Cite
Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy
MLA
Hui Lin, et al. “Dihydromyricetin Prevents Diabetic Cardiomyopathy via MiR-34a Suppression by Activating Autophagy.” Cardiovascular Drugs and Therapy, vol. 34, no. 3, Mar. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d35c4eeec1df3a7ffe7d534913655cc8&authtype=sso&custid=ns315887.
APA
Hui Lin, Tingjuan Ni, Hangyuan Guo, Zhenzhu Sun, Na Lin, Jufang Chi, & Wenqiang Lu. (2020). Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy. Cardiovascular Drugs and Therapy, 34(3).
Chicago
Hui Lin, Tingjuan Ni, Hangyuan Guo, Zhenzhu Sun, Na Lin, Jufang Chi, and Wenqiang Lu. 2020. “Dihydromyricetin Prevents Diabetic Cardiomyopathy via MiR-34a Suppression by Activating Autophagy.” Cardiovascular Drugs and Therapy 34 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d35c4eeec1df3a7ffe7d534913655cc8&authtype=sso&custid=ns315887.